CAPTRUST FINANCIAL ADVISORS - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 202 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,364,061
-10.7%
65,454
+2.6%
0.01%
-16.7%
Q2 2023$1,527,268
+10081.8%
63,769
+5967.5%
0.01%
Q2 2022$15,000
-71.7%
1,051
-51.9%
0.00%
Q1 2022$53,000
+8.2%
2,184
+4.9%
0.00%
Q4 2021$49,000
+250.0%
2,081
+156.0%
0.00%
Q3 2021$14,000
-74.1%
813
-62.9%
0.00%
-100.0%
Q2 2021$54,000
-18.2%
2,194
-13.7%
0.00%0.0%
Q1 2021$66,000
-30.5%
2,543
+42.5%
0.00%0.0%
Q4 2020$95,000
+1087.5%
1,785
+1090.0%
0.00%
Q2 2020$8,000
-11.1%
150
-57.1%
0.00%
Q2 2019$9,0000.0%3500.0%0.00%
Q1 2019$9,000
+50.0%
3500.0%0.00%
Q4 2018$6,000
-60.0%
350
-51.2%
0.00%
-100.0%
Q3 2018$15,0000.0%717
-29.4%
0.00%0.0%
Q2 2018$15,000
+66.7%
1,015
+125.6%
0.00%0.0%
Q1 2018$9,000
-47.1%
450
-18.2%
0.00%0.0%
Q4 2017$17,000
+70.0%
550
+57.1%
0.00%
Q3 2017$10,0003500.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders